Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Statin Therapy for Lowering LDL Cholesterol

Introduction to Statin Benefits

  • The American College of Cardiology recommends statin therapy as the most powerful and proven treatment for lowering LDL cholesterol, reducing the risk of heart attacks, strokes, and death from cardiovascular disease by approximately 20-37%, with every 40 mg/dL reduction in LDL translating to a 20% improvement in outcomes 1, 2

Proven Mortality and Morbidity Benefits

  • Statins reduce all-cause mortality by 9% and cardiovascular death by 13% for each 39 mg/dL reduction in LDL cholesterol, according to the American Diabetes Association 1
  • Clinical trials involving over 50,000 patients with an average follow-up of 5.4 years have demonstrated clear reductions in heart attacks, need for heart procedures, strokes, peripheral vascular disease, and overall death rates, as reported by the American Heart Association 2, 3
  • These benefits apply to both men and women, whether they already have heart disease or are trying to prevent their first event, as stated by the American College of Cardiology 2, 3

LDL Cholesterol as the Primary Target

  • Elevated LDL cholesterol is the prime driver of atherosclerosis, and reducing it is crucial for minimizing heart disease risk, according to the Journal of the American College of Cardiology 4
  • The degree of risk reduction depends on how much LDL is lowered, not which specific treatment is used, as reported by the American College of Cardiology 4
  • Statins are the most effective option, lowering LDL by 35-55% depending on the type and dose, compared to only 10-20% with other medications, as stated by the American Heart Association 4

Statin Dosage and Patient Risk

  • Patients with established heart disease or very high risk should receive high-intensity statin therapy to achieve at least a 50% reduction in LDL cholesterol, according to the American College of Cardiology 1, 5
  • The LDL goal should be below 70 mg/dL, and ideally below 55 mg/dL if the patient is at very high risk, as recommended by the American Heart Association 1, 5
  • High-intensity statins reduce major cardiovascular events by 22% and all-cause mortality by 10% per 1.0 mmol/L (39 mg/dL) reduction in LDL, as reported by the American College of Cardiology 5

Patient-Specific Recommendations

  • Patients with diabetes should take at least moderate-intensity statin therapy regardless of their starting LDL level, according to the American Diabetes Association 1
  • Patients with diabetes plus established heart disease need high-intensity statin therapy, as stated by the American College of Cardiology 1
  • Patients with multiple cardiovascular risk factors should start moderate-intensity statin therapy, according to the American Heart Association 1

Safety and Tolerability

  • Statins are well tolerated by most people, with serious side effects being extremely rare, as reported by the American College of Cardiology 2, 3
  • No serious morbidity or increase in mortality was observed in statin-treated groups in clinical trials with over 50,000 patients, according to the American Heart Association 2, 3
  • Elevated liver enzymes occur in only 0.5-2% of cases and are dose-dependent, with progression to liver failure being exceedingly rare, as stated by the American College of Cardiology 3

Common Concerns Addressed

  • Muscle aches can occur, but serious muscle breakdown is extremely rare with modern statins, according to the American Heart Association 6, 2
  • If side effects occur, the doctor can try a different statin or lower dose, as recommended by the American College of Cardiology 1, 7

Additional Medications

  • If the patient doesn't reach their LDL goal on maximum tolerated statin therapy, the doctor should add ezetimibe, which provides an additional 20-25% LDL reduction, according to the American College of Cardiology 5
  • For very high-risk patients who still don't reach goal, PCSK9 inhibitors can be added for an additional 60% LDL reduction, as stated by the American Heart Association 5

Critical Points to Remember

  • Statins work regardless of the starting LDL level, and the benefit comes from the absolute reduction in LDL, not from reaching a specific target number, according to the Journal of the American College of Cardiology 8
  • Statins are easy to take, have few drug interactions, and are generally well accepted by patients, as reported by the American College of Cardiology 2, 3
  • The cardiovascular benefits of statins have been proven in rigorous clinical trials and are endorsed by all major cardiology guidelines, according to the American Heart Association 2, 3